Aberrant expression of CD7 in acute myeloid leukemias with FLT3-ITD

被引：0
|
作者：
Junca, Jordi [1 ]
Zamora, Lurdes [1 ]
Cabezon, Marta [1 ]
Marce, Silvia [1 ]
Nomdedeu, Josep [2 ]
机构：
[1] Hosp Badalona Germans Trias & Pujol, Dept Hematol, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2008年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：644 / 644
页数：1
相关论文
共 50 条
  • [21] Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations
    Scholl, Sebastian
    Melle, Christian
    Bleul, Annett
    Spies-Weisshart, Baerbel
    Kunert, Christa
    Hoffken, Klaus
    Von Eggeling, Ferdinand
    LEUKEMIA & LYMPHOMA, 2007, 48 (12) : 2418 - 2423
  • [22] FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients with Acute Leukemias
    Vela-Ojeda, Jorge
    Cardenas, Pamela Vazquez
    Esparza, Miriam A. Garcia-Ruiz
    Cervantes, Laura Arcelia Montiel
    Chavez, Jaime Garcia
    Caballero, Alvaro Hernandez
    Majluf-Cruz, Abraham
    Vega-Lopez, Armando
    Reyes-Maldonado, Elba
    ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (02) : 217 - 223
  • [23] CD123 Immunohistochemical Expression in Acute Myeloid Leukemia Is Associated with FLT3-ITD but Not NPM1 Mutations
    Rollins-Raval, M. A.
    Pillai, R. K.
    Djokic, M.
    Kant, J. A.
    Roth, C. G.
    LABORATORY INVESTIGATION, 2012, 92 : 365A - 365A
  • [24] Higher CD97 expression in acute myeloid leukemia is associated with FLT3-ITD and NPM1 mutation
    Wobus, M.
    Bornhaeuser, M.
    Ortlepp, C.
    Ehninger, G.
    Thiede, C.
    Oelschlaegel, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 225 - 225
  • [25] FLT3 AND FLT3-ITD GENE MUTATIONS AND PROGNOSIS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Chen, L. G.
    Pei, R. Z.
    Lu, Y.
    Zhang, P. S.
    Liu, X. H.
    Du, X. H.
    Chen, D.
    Cao, J. J.
    Li, S. Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (06): : 1855 - 1861
  • [26] CD123 Immunohistochemical Expression in Acute Myeloid Leukemia Is Associated with FLT3-ITD but Not NPM1 Mutations
    Rollins-Raval, M. A.
    Pillai, R. K.
    Djokic, M.
    Kant, J. A.
    Roth, C. G.
    MODERN PATHOLOGY, 2012, 25 : 365A - 365A
  • [27] The Diversity of FLT3-ITD and the Prognostic Impact in Adult Acute Myeloid Leukemia
    Yang, Jingyi
    Mo, Shanlan
    Wei, Xudong
    Lv, Xiaodong
    Fang, Baijun
    Zhang, Yanli
    Zhou, Jian
    Zhou, Hu
    Fu, Yuewen
    Lin, Quande
    Liu, Delong
    Song, Yongping
    Wang, Qianfei
    Zhou, Keshu
    BLOOD, 2023, 142
  • [28] Clinical importance of mutation types of FLT3-ITD in acute myeloid leukemia
    Kim, Seon Young
    Park, Yun Mi
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 551 - 551
  • [29] Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia
    Lam, Stephen S. Y.
    Ho, Eric S. K.
    He, Bai-Liang
    Wong, Wui-Wing
    Cher, Chae-Yin
    Ng, Nelson K. L.
    Man, Cheuk-Him
    Gill, Harinder
    Cheung, Alice M. S.
    Ip, Ho-Wan
    So, Chi-Chiu
    Tamburini, Jerome
    So, Chi Wai Eric
    Ho, Dona N.
    Au, Chun-Hang
    Chan, Tsun-Leung
    Ma, Edmond S. K.
    Liang, Raymond
    Kwong, Yok-Lam
    Leung, Anskar Y. H.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (359)
  • [30] Validation of FLT3-ITD As a Therapeutic Target in Human Acute Myeloid Leukemia
    Smith, Catherine C.
    Chin, Jason
    Wang, Qi
    Salerno, Sara
    Damon, Lauren E.
    Hunt, Jeremy P.
    Levis, Mark J.
    Perl, Alexander E.
    Travers, Kevin
    Wang, Susana
    Kasarskis, Andrew
    Schadt, Eric
    Kuriyan, John
    Shah, Neil
    BLOOD, 2011, 118 (21) : 426 - 427
12345